An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret

被引:55
作者
Rudd, JA [1 ]
Naylor, RJ [1 ]
机构
[1] UNIV BRADFORD, SCH PHARM, BRADFORD BD7 1DP, W YORKSHIRE, ENGLAND
关键词
emesis; cisplatin; acute and delayed; ondansetron; dexamethasone; ferret model;
D O I
10.1111/j.1476-5381.1996.tb15388.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Cisplatin, 5 mg kg(-1), i.p., administered as a single treatment, induced an acute (day 1) and delayed (days 2 and 3) emetic response in the ferret that was used to investigate the potential anti-emetic activity of ondansetron and dexamethasone and their interaction over a three day period. 2 Ondansetron, 1 mg kg(-1), i.p., administered three times per day in two experiments, antagonized significantly the retching and vomiting that occurred on days 1 and 2 by 60-76 and 73-84%. On the third day of treatment there was a trend for a 38% reduction in one experiment and a 74% reduction in the other. 3 There was a trend for dexamethasone, 1 mg kg(-1), i.p., administered as a single daily injection for three days, to reduce by 37% the retching and vomiting response that occurred on day 1, the reduction of 77% on day 2 achieved significance and dexamethasone non-significantly increased the retching and vomiting response by 46% on day 3. However, dexamethasone 1 mg kg(-1) i.p. administered three times per day for three days significantly reduced the retching + vomiting reponse by 85, 97 and 86% on days 1, 2 and 3 respectively. 4 The combination of dexamethasone, 1 mg kg(-1), i.p., as single daily injections with ondansetron, 1 mg kg(-1), i.p., administered three times per day improved the control of the retching and vomiting response, significantly reducing the total numbers of retches and vomits by more than 70% over a three day period. The combination of dexamethasone (1.0 mg kg(-1)) and ondansetron (1.0 mg kg(-1)), both administered three times daily, abolished cisplatin-induced emesis over the three day period. 5 The three times per day administration of ondansetron, 1 mg kg(-1) i.p., plus dexamethasone, 1 mg kg(-1), i.p., administered only on day 1 prevented day 1 emesis but did not modify the retching and vomiting that occurred on days 2 and 3. 6 The present results indicate that ondansetron and dexamethasone significantly reduce cisplatin-induced emesis in the ferret during both the acute and delayed phase; drug/co-treatment can exert an additive action to abolish cisplatin-induced emesis. The ferret model may be useful to detect anti-emetic drug action for treatment of chemotherapy-induced acute and delayed emesis in man.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 26 条
[1]  
AAPRO MS, 1992, COLLOQ INSE, V223, P141
[2]   NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[3]  
BAXENDALE BR, 1993, ANAESTHESIA, V48, P961
[4]   THE ANTI-EMETIC POTENTIAL OF THE 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONIST BRL-43694 [J].
BERMUDEZ, J ;
BOYLE, EA ;
MINER, WD ;
SANGER, GJ .
BRITISH JOURNAL OF CANCER, 1988, 58 (05) :644-650
[5]   A RANDOMIZED TRIAL OF DEXAMETHASONE, LORAZEPAM AND PROCHLORPERAZINE FOR EMESIS IN PATIENTS RECEIVING CHEMOTHERAPY [J].
BISHOP, JF ;
MATTHEWS, JP ;
WOLF, MM ;
OLIVER, IN ;
REYNOLDS, S ;
WALPOLE, E ;
RISCHIN, D ;
BUCHANAN, L ;
TAN, LG .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) :47-50
[6]  
CERSOSIMO RJ, 1986, PHARMACOTHERAPY, V6, P118
[7]   PHENYTOIN IMPAIRS THE BIOAVAILABILITY OF DEXAMETHASONE IN NEUROLOGICAL AND NEUROSURGICAL PATIENTS [J].
CHALK, JB ;
RIDGEWAY, K ;
BROPHY, TRO ;
YELLAND, JDN ;
EADIE, MJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1984, 47 (10) :1087-1090
[8]   METHYLPREDNISOLONE ENHANCES THE EFFICACY OF ONDANSETRON IN ACUTE AND DELAYED CISPLATIN-INDUCED EMESIS OVER AT LEAST 3 CYCLES [J].
CHEVALLIER, B ;
MARTY, M ;
PAILLARSE, JM .
BRITISH JOURNAL OF CANCER, 1994, 70 (06) :1171-1175
[9]   NAUSEA IN CANCER-CHEMOTHERAPY IS INVERSELY RELATED TO URINARY CORTISOL EXCRETION [J].
FREDRIKSON, M ;
HURSTI, T ;
FURST, CJ ;
STEINECK, G ;
BORJESON, S ;
WIKBLOM, M ;
PETERSON, C .
BRITISH JOURNAL OF CANCER, 1992, 65 (05) :779-780
[10]   DELAYED EMESIS FOLLOWING HIGH-DOSE CISPLATIN - A DOUBLE-BLIND RANDOMIZED COMPARATIVE TRIAL OF ONDANSETRON (GR-38032F) VERSUS PLACEBO [J].
GANDARA, DR ;
HARVEY, WH ;
MONAGHAN, GG ;
PEREZ, EA ;
HESKETH, PJ .
EUROPEAN JOURNAL OF CANCER, 1993, 29A :S35-S38